flash nanoprecipitation
Recently Published Documents


TOTAL DOCUMENTS

85
(FIVE YEARS 37)

H-INDEX

21
(FIVE YEARS 5)

Author(s):  
Kohei Yamada ◽  
Kurt D. Ristroph ◽  
Yuki Kaneko ◽  
Hoang D. Lu ◽  
Hideyuki Sato ◽  
...  

2021 ◽  
Author(s):  
Hayden M Pagendarm ◽  
Payton T Stone ◽  
Jessalyn J Baljon ◽  
Mina H Aziz ◽  
Lucinda E Pastora ◽  
...  

The delivery of biomacromolecular drugs to cytosolic targets has been a long-standing engineering challenge due to the presence of multiple biological barriers including cellular and endosomal membranes. Although many promising carriers designed to facilitate endosomal escape have been developed, the clinical translation of these carriers is often limited by complex production processes that are not amenable to scaled-up manufacturing. In this study, we employed flash nanoprecipitation (FNP) for the rapid, scalable, and reproducible assembly of nanocarriers composed of the pH-responsive, endosomolytic diblock copolymer poly[(ethylene glycol)x-block-[((2-diethylamino) ethyl methacrylate)0.6-co-(butyl methacrylate)0.4]y (PEG-b-DEAEMA-co-BMA). We found that varying the second block molecular weight, while holding the first block molecular weight constant, significantly influenced nanoparticle self-assembly and hence nanocarrier properties and function – including drug encapsulation, endosomolytic capacity, cytotoxicity, and in vitro activity of a cytosolically-active drug cargo, a cyclic dinucleotide (CDN) stimulator of interferon genes (STING) agonist. We found that while increasing second block molecular weight enhanced the capacity of nanocarriers to induce endosomal destabilization, larger second block molecular weights also lead to increased cytotoxicity, increased particle size and heterogeneity, increased the encapsulation efficiency of small (<0.5 kDa) hydrophilic drugs, decreased the encapsulation efficiency of large (10 kDa) hydrophilic biomacromolecules, and decreased long-term particle stability. Collectively, these results demonstrate the utility of FNP for the rapid and scalable production of uniform PEG-b-DEAEMA-co-BMA nanocarriers and implicate an optimal hydrophilic mass fraction for balancing desirable nanoparticle properties with cytosolic cargo delivery efficiency.


Author(s):  
William N. Sharratt ◽  
Victoria E. Lee ◽  
Rodney D. Priestley ◽  
João T. Cabral

2021 ◽  
pp. 130523
Author(s):  
Rizwan Ahmed Bhutto ◽  
Zhinan Fu ◽  
Mingwei Wang ◽  
Jie Yu ◽  
Fang Zhao ◽  
...  

Author(s):  
Ming Liu ◽  
Chenxu Yan ◽  
Jianwei Han ◽  
Zhiqian Guo ◽  
Yue Wu ◽  
...  

Author(s):  
Lijun Ji ◽  
Tong Xu ◽  
Jun Gu ◽  
Qingren Liu ◽  
Shu Zhou ◽  
...  

AbstractNanoscale bioactive glass particles have greater bioactivity than microscale bioactive glass particles, due to their high-specific surface area and fast ion release rate in body fluid. However, preparation of bioactive glass nanoparticles (BGNPs) is difficult since calcium is not easy to be highly doped into the forming silica atom network, leading to an uneven distribution and a low content of calcium. In addition, BGNPs are usually prepared in a dilute solution to avoid agglomeration of the nanoparticles, which decreases the production efficiency and increases the cost. In this work, BGNPs are prepared by a method of the reactive flash nanoprecipitation (RFNP) as well as a traditional sol–gel method. The results indicate that the BGNPs by the RFNP present a smaller size, narrower size distribution, more uniform composition, and better bioactivity than those by the traditional sol–gel method. The obtained BGNPs have uniform compositions close to the feed values. The high and even doping of calcium in the BGNPs is achieved. This successful doping of calcium into nanoparticles by the RFNP demonstrates a promising way to effectively generate high-quality BGNPs for bone repairs.


Sign in / Sign up

Export Citation Format

Share Document